Healing Trauma with MDMA: A New Study Published

Findings from the last study in a series of six Phase 2 trials of MDMA-assisted psychotherapy for treatment of post-traumatic stress disorder (PTSD) was published today in the Journal of Psychopharmacology. The clinical trial in Boulder, Colorado (MP-12) enrolled 28 participants suffering from chronic PTSD. Results showed that after 2 - 3 sessions of MDMA psychotherapy (with active doses of MDMA ie:100 to 125 mg) PTSD symptoms were markedly reduced. One year later most of the participants (76%) no longer meet criteria for PTSD.